Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA v. Thompson

Executive Summary

Washington, D.C. appeals court is scheduled to hear oral arguments in the Pharmaceutical Research & Manufacturers of America's case against HHS' approval of the Healthy Maine Prescription demonstration program Dec. 5. The D.C. federal court ruled that the program qualifies for manufacturer rebates (1'The Pink Sheet" March 4, p. 13)...

Washington, D.C. appeals court is scheduled to hear oral arguments in the Pharmaceutical Research & Manufacturers of America's case against HHS' approval of the Healthy Maine Prescription demonstration program Dec. 5. The D.C. federal court ruled that the program qualifies for manufacturer rebates (1 (Also see "Maine Medicaid Waiver Qualifies For Rx Rebates By State Contributions – Court" - Pink Sheet, 4 Mar, 2002.), p. 13)....

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040878

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel